Lucid Diagnostics Inc (LUCD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LUCD Annual Balance Sheets →
The balance sheet data below highlights changes in Lucid Diagnostics Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent33.40
Cash & Short-term Investments33.00
Accounts receivable1.09
Inventories0.48
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.84
Total Current Assets36.62
Equipment/Property/Plant Net0.81
Intangible Assets0.11
Other Assets, Noncurrent1.41
Operating Lease Right Of Use Asset1.59
Total Assets38.95
Liabilities
Accounts Payable, Current AC0.67
Accrued Liabilities, Current AC2.44
Convertible Notes Payable, Current NO23.50
Other Liabilities, Current0.91
Total Current Liabilities27.52
Total Long-term Debt0.00
Other liabilities, Noncurrent0.50
Operating Lease Liability Current0.91
Operating Lease Liability Noncurrent0.70
Total Liabilities28.02
Stockholders' Equity
Common Stock Value0.19
Additional Paid In Capital Common Stock323.41
Retained Earnings / Accumulated Deficit-312.68
Other Equity0.00
Common Stockholder's Equity10.93
Preferred Stockholder's Equity0.00
Total Stockholder's Equity10.93
Liabilities & Stockholder's Equity38.95
4 historic quarters locked

Sign in to unlock the full Lucid Diagnostics Inc balance sheet history.

About Lucid Diagnostics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-027335

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.